Securing retatrutide can be a hurdle for many. Currently, it's is restricted and requires a prescription from a medical provider. Obtaining retatrutide typically involves participating in a clinical trial , though potential expanded release through traditional prescription routes is under review – though the schedule for this remains undefined .